| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |